Cargando…
Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients
BACKGROUND: Cytogenetic testing (CGT) in uveal melanoma patients reveals prognostic information about the individual risk of developing distant metastasis with dismal prognosis. There is currently no medical intervention strategy with proven effect on the prognosis, rendering the result of the cytog...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135859/ https://www.ncbi.nlm.nih.gov/pubmed/35355121 http://dx.doi.org/10.1007/s00520-022-07006-5 |
_version_ | 1784714055481556992 |
---|---|
author | Gollrad, Johannes Korpusik, Nevenka Rabsahl, Christopher Boehmer, Dirk Besserer, Angela Grittner, Ulrike Boeker, Alexander Keilholz, Ulrich Joussen, Antonia Budach, Volker Goerling, Ute |
author_facet | Gollrad, Johannes Korpusik, Nevenka Rabsahl, Christopher Boehmer, Dirk Besserer, Angela Grittner, Ulrike Boeker, Alexander Keilholz, Ulrich Joussen, Antonia Budach, Volker Goerling, Ute |
author_sort | Gollrad, Johannes |
collection | PubMed |
description | BACKGROUND: Cytogenetic testing (CGT) in uveal melanoma patients reveals prognostic information about the individual risk of developing distant metastasis with dismal prognosis. There is currently no medical intervention strategy with proven effect on the prognosis, rendering the result of the cytogenetic testing purely informative. We explored patients’ socio-demographic backgrounds, psychological preconditions, coping strategies, external influences, and concerns about “knowing their fate” to study their possible interactions with decision-making for CGT. METHODS: Uveal melanoma patients were asked to complete questionnaires on their interest in undergoing CGT for prognostication and the factors influencing their decision. Data were collected on socio-demographics, baseline anxiety (GAD-7), depression (PHQ-9), coping strategies (Brief COPE), and assumed future concerns regarding the CGT result. Data were analyzed by using multiple ordinal logistic regression and exploring estimated marginal effects. RESULTS: Questionnaires were returned by 121 of 131 (92.4%) patients. Fifty-two patients (43%) had no interest in CGT, 34 (28.1%) were undecided, and 35 (28.9%) were interested. We observed no significant differences regarding age, sex, partnership, education, occupation, baseline anxiety, or depression. Decision-making favoring CGT was influenced by the treating physicians, internet resources, and level of baseline anxiety. Patients were likely to reject CGT when they worried that “knowing the result will have an unintended influence” on their life. CONCLUSION: Decision-making about CGT for prognostication in uveal melanoma is burdensome to many patients and in general not guided by medical advice regarding further treatment and screening procedures. The psychological impact of the decision is therefore unique and requires careful support by psycho-oncologists considering the patient’s fears and expectations. |
format | Online Article Text |
id | pubmed-9135859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-91358592022-05-28 Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients Gollrad, Johannes Korpusik, Nevenka Rabsahl, Christopher Boehmer, Dirk Besserer, Angela Grittner, Ulrike Boeker, Alexander Keilholz, Ulrich Joussen, Antonia Budach, Volker Goerling, Ute Support Care Cancer Original Article BACKGROUND: Cytogenetic testing (CGT) in uveal melanoma patients reveals prognostic information about the individual risk of developing distant metastasis with dismal prognosis. There is currently no medical intervention strategy with proven effect on the prognosis, rendering the result of the cytogenetic testing purely informative. We explored patients’ socio-demographic backgrounds, psychological preconditions, coping strategies, external influences, and concerns about “knowing their fate” to study their possible interactions with decision-making for CGT. METHODS: Uveal melanoma patients were asked to complete questionnaires on their interest in undergoing CGT for prognostication and the factors influencing their decision. Data were collected on socio-demographics, baseline anxiety (GAD-7), depression (PHQ-9), coping strategies (Brief COPE), and assumed future concerns regarding the CGT result. Data were analyzed by using multiple ordinal logistic regression and exploring estimated marginal effects. RESULTS: Questionnaires were returned by 121 of 131 (92.4%) patients. Fifty-two patients (43%) had no interest in CGT, 34 (28.1%) were undecided, and 35 (28.9%) were interested. We observed no significant differences regarding age, sex, partnership, education, occupation, baseline anxiety, or depression. Decision-making favoring CGT was influenced by the treating physicians, internet resources, and level of baseline anxiety. Patients were likely to reject CGT when they worried that “knowing the result will have an unintended influence” on their life. CONCLUSION: Decision-making about CGT for prognostication in uveal melanoma is burdensome to many patients and in general not guided by medical advice regarding further treatment and screening procedures. The psychological impact of the decision is therefore unique and requires careful support by psycho-oncologists considering the patient’s fears and expectations. Springer Berlin Heidelberg 2022-03-31 2022 /pmc/articles/PMC9135859/ /pubmed/35355121 http://dx.doi.org/10.1007/s00520-022-07006-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Gollrad, Johannes Korpusik, Nevenka Rabsahl, Christopher Boehmer, Dirk Besserer, Angela Grittner, Ulrike Boeker, Alexander Keilholz, Ulrich Joussen, Antonia Budach, Volker Goerling, Ute Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients |
title | Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients |
title_full | Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients |
title_fullStr | Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients |
title_full_unstemmed | Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients |
title_short | Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients |
title_sort | fear of prognosis? how anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135859/ https://www.ncbi.nlm.nih.gov/pubmed/35355121 http://dx.doi.org/10.1007/s00520-022-07006-5 |
work_keys_str_mv | AT gollradjohannes fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT korpusiknevenka fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT rabsahlchristopher fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT boehmerdirk fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT bessererangela fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT grittnerulrike fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT boekeralexander fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT keilholzulrich fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT joussenantonia fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT budachvolker fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients AT goerlingute fearofprognosishowanxietycopingandexpectedburdenimpactthedecisiontohavecytogeneticassessmentinuvealmelanomapatients |